EP2854852 - COMPOSITIONS AND METHODS FOR TREATING CROHN'S DISEASE AND RELATED CONDITIONS AND INFECTIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.10.2020 Database last updated on 09.09.2024 | |
Former | Examination is in progress Status updated on 27.04.2018 | Most recent event Tooltip | 02.10.2020 | Application deemed to be withdrawn | published on 04.11.2020 [2020/45] | Applicant(s) | For all designated states Agrawal, Gaurav Unit 1 2 Malvern Ave. Manly, NSW 2095 / AU | [2018/49] |
Former [2016/38] | For all designated states Centre for Digestive Diseases Level 1 229 Great North Road Five Dock, NSW 2046 / AU | ||
Former [2016/29] | For all designated states CENTRE FOR DIGESTIVE DISEASES PTY LTD Level 1 229 Great North Road Five Dock, NSW 2046 / AU | ||
Former [2015/15] | For all designated states Agrawal, Gaurav Unit 1, 2 Malvern Avenue Manly, New South Wales 2095 / AU | Inventor(s) | 01 /
AGRAWAL Gaurav 3/14 Cove Avenue Manly, New South Wales 2095 / AU | [2016/38] |
Former [2015/15] | 01 /
see applicant ... | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2015/15] | Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 13801095.4 | 04.06.2013 | WO2013AU00587 | Priority number, date | AU20120902307 | 04.06.2012 Original published format: AU 2012902307 | [2015/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013181694 | Date: | 12.12.2013 | Language: | EN | [2013/50] | Type: | A1 Application with search report | No.: | EP2854852 | Date: | 08.04.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.12.2013 takes the place of the publication of the European patent application. | [2015/15] | Search report(s) | International search report - published on: | AU | 12.12.2013 | (Supplementary) European search report - dispatched on: | EP | 16.03.2016 | Classification | IPC: | A61K39/395, A61P31/04, A61P1/00, A23C9/123, A23G4/06, A23G9/32, A23G3/36, A61K39/40, A61K31/133, A61K31/4164, A61K31/435, A61K31/496, A61K31/498, A61K31/00 | [2016/15] | CPC: |
A61K31/133 (EP,US);
A61K39/395 (IL);
A61K39/39533 (US);
A23C9/123 (US);
A23G3/36 (US);
A23G4/06 (US);
A23G9/32 (US);
A61K31/4164 (EP,US);
A61K31/435 (EP,US);
A61K31/496 (EP,US);
A61K31/498 (EP,IL,US);
A61K31/7048 (EP,IL,US);
A61K33/00 (EP,US);
A61K39/3955 (EP,US);
A61K39/40 (EP,IL,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P29/00 (EP);
A61P31/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
| C-Set: |
A61K39/3955, A61K39/00 (US,IL,EP);
A61K39/40, A61K39/00 (IL,EP,US) |
Former IPC [2015/15] | A61K39/395, A61P31/04, A61P1/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/15] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MORBUS CROHN UND VERWANDTEN ERKRANKUNGEN UND INFEKTIONEN | [2015/15] | English: | COMPOSITIONS AND METHODS FOR TREATING CROHN'S DISEASE AND RELATED CONDITIONS AND INFECTIONS | [2015/15] | French: | COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE LA MALADIE DE CROHN ET DES PATHOLOGIES ET INFECTIONS ASSOCIÉES | [2015/15] | Entry into regional phase | 18.12.2014 | National basic fee paid | 18.12.2014 | Search fee paid | 18.12.2014 | Designation fee(s) paid | 18.12.2014 | Examination fee paid | Examination procedure | 18.12.2014 | Examination requested [2015/15] | 10.10.2016 | Amendment by applicant (claims and/or description) | 03.05.2018 | Despatch of a communication from the examining division (Time limit: M06) | 09.11.2018 | Reply to a communication from the examining division | 13.03.2019 | Invitation to indicate the basis for amendments (Time limit: M01) | 01.04.2019 | Reply to an invitation to indicate the basis for amendments | 30.04.2019 | Despatch of a communication from the examining division (Time limit: M06) | 08.11.2019 | Reply to a communication from the examining division | 21.11.2019 | Despatch of a communication from the examining division (Time limit: M06) | 03.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/45] | 25.06.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/45] | Divisional application(s) | EP20152020.2 / EP3659598 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.05.2018 | Fees paid | Renewal fee | 29.06.2015 | Renewal fee patent year 03 | 14.12.2016 | Renewal fee patent year 04 | 16.06.2017 | Renewal fee patent year 05 | 12.06.2018 | Renewal fee patent year 06 | 13.06.2019 | Renewal fee patent year 07 | 31.03.2020 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.06.2016 | 04   M06   Fee paid on   14.12.2016 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY] - JOHN HERMON-TAYLOR, "Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario", GUT PATHOGENS, London, UK, (20090101), vol. 1, no. 1, doi:10.1186/1757-4749-1-15, ISSN 1757-4749, page 15, XP055221937 [I] 1-12 * page 4, column r, paragraph 22 - paragraph 3 * [Y] 1-12 DOI: http://dx.doi.org/10.1186/1757-4749-1-15 | [XY] - R. L. WEST ET AL, "Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study", ALIMENTARY PHARMACOLOGY & THERAPEUTICS., GB, (20041201), vol. 20, no. 11-12, doi:10.1111/j.1365-2036.2004.02247.x, ISSN 0269-2813, pages 1329 - 1336, XP055222095 [X] 1,3,4,6,7,11,12 * page 1334, column l * * table 1 * [Y] 1-12 DOI: http://dx.doi.org/10.1111/j.1365-2036.2004.02247.x | [XY] - KATSANOS K H ET AL, "Fournier's gangrene complicating ulcerative pancolitis", JOURNAL OF CROHN'S AND COLITIS, ELSEVIER BV, NL, vol. 4, no. 2, ISSN 1873-9946, (20100601), pages 203 - 206, (20100512), XP027047690 [X] 1,3,4,7,11,12 * page 205, column r, paragraph 1 * [Y] 1-12 | International search | [X]WO2007120720 (ABBOTT BIOTECH LTD, et al); | [X] - JIANG, T. ET AL., "Fournier gangrene associated with Crohn disease", MAYO CLIN PROC., (2000), vol. 75, no. 6, pages 647 - 649, XP055178933 DOI: http://dx.doi.org/10.4065/75.6.647 | [A] - LAVY, A. ET AL., "Hyperbaric oxygen for perianal Crohn's disease", J CLIN GASTROENTEROL., (1994), vol. 19, no. 3, pages 202 - 205, XP008175670 DOI: http://dx.doi.org/10.1097/00004836-199410000-00006 | [A] - ROSSIGNOL, D. A., "Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis", MEDICAL GAS RESEARCH, (2012), vol. 2, no. 1, page 6, XP021124451 DOI: http://dx.doi.org/10.1186/2045-9912-2-6 | [X] - NELSON, E. W. JR. ET AL., "Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management", DIG DIS SCI., (1990), vol. 35, no. 12, pages 1561 - 1565, XP008175676 DOI: http://dx.doi.org/10.1007/BF01540577 |